Suspicious Ultrasound-Occult Non-Calcified Mammographic Masses, Asymmetries, and Architectural Distortions Are Moderate Probability for Malignancy

Author:

Cohen Ethan O.1ORCID,Perry Rachel E.1,Legha Ravinder S.1,Tso Hilda H.1ORCID,Shin Kyungmin1,Speer Megan E.1,Phalak Kanchan A.1,Sun Jia2,Leung Jessica W. T.1

Affiliation:

1. Department of Breast Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

2. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

Abstract

Suspicious non-calcified mammographic findings have not been evaluated with modern mammographic technique, and the purpose of this work is to compare the likelihood of malignancy for those findings. To do this, 5018 consecutive mammographically guided biopsies performed during 2016–2019 at a large metropolitan, community-based hospital system were retrospectively reviewed. In total, 4396 were excluded for targeting calcifications, insufficient follow-up, or missing data. Thirty-seven of 126 masses (29.4%) were malignant, 44 of 194 asymmetries (22.7%) were malignant, and 77 of 302 architectural distortions (AD, 25.5%) were malignant. The combined likelihood of malignancy was 25.4%. Older age was associated with a higher likelihood of malignancy for each imaging finding type (all p ≤ 0.006), and a possible ultrasound correlation was associated with a higher likelihood of malignancy when all findings were considered together (p = 0.012). Two-view asymmetries were more frequently malignant than one-view asymmetries (p = 0.03). There were two false-negative biopsies (98.7% sensitivity and 100% specificity). In conclusion, the 25.4% likelihood of malignancy confirms the recommendation for biopsy of suspicious, ultrasound-occult, mammographic findings. Mammographically guided biopsies were highly sensitive and specific in this study. Older patient age and a possible ultrasound correlation should raise concern given the increased likelihood of malignancy in those scenarios.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference33 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022

2. Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women;Duffy;Cancer,2020

3. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening;Dean;Cancer,2019

4. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties;Duffy;Cancer,2002

5. D’Orsi, C., Sickles, E., Mendelson, E., and Morris, E. (2013). ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System, American College of Radiology.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3